Latest Research
All publications from the Cancer3.AI database, newest first.
Idiopathic pulmonary fibrosis predicts local recurrence following surgery in patients with non-small cell lung cancer.
Maeda R, et al
Researchers examined whether idiopathic pulmonary fibrosis (IPF), a chronic progressive lung-scarring disease, influences the risk of local cancer recurrence in patients who underwent surgical resection for non-small cell lung cancer (NSCLC). The study identified IPF as a significant independent predictor of local recurrence following surgery in NSCLC patients, meaning tumors were more likely to return at or near the original surgical site in patients who also had IPF. These findings suggest that the fibrotic lung microenvironment may create conditions that promote residual cancer cell survival or impair complete surgical clearance. For clinicians, the results highlight the importance of preoperatively identifying IPF in NSCLC surgical candidates, as this comorbidity may warrant intensified postoperative surveillance or consideration of adjuvant therapies. Ultimately, this work supports a more individualized, risk-stratified approach to managing the growing number of patients who present with both IPF and lung cancer.
Journal of cancer research and clinical oncology
Source →Impact of lung cancer diagnosis on patient lifestyle and physical activity.
Marín AJ, et al
A new study from Castilla-La Mancha, Spain, examined how a lung cancer diagnosis changes patients' lifestyle habits, physical activity, diet quality, and health-related quality of life (HRQoL) by comparing self-reported behaviors from one year before diagnosis with those reported after diagnosis among 53 lung cancer patients from three hospitals. The most striking positive finding was a significant reduction in cigarette consumption following diagnosis, confirming that a cancer diagnosis can be a powerful motivator for smoking cessation. However, the study also revealed concerning declines in fruit and vegetable consumption, dietary fiber intake, and overall HRQoL across domains including mobility, self-care, and pain management, while physical activity levels also trended downward, though not significantly. Adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) cancer prevention recommendations did not improve after diagnosis despite the opportunity for health behavior change. These findings underscore a critical gap in oncology care: while patients may spontaneously reduce smoking, other lifestyle factors that are equally important for long-term outcomes are often neglected or worsen following diagnosis. The authors call for targeted, multidisciplinary interventions delivered at the point of diagnosis to help lung cancer patients maintain healthy diets and adequate physical activity throughout their treatment and recovery.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Source →Five-year prognostic impact of pre-existing interstitial lung disease in non-small cell lung cancer patients treated with anti-PD-1 monotherapy: a retrospective analysis.
Yamaguchi T, et al
This retrospective study investigated whether pre-existing interstitial lung disease (ILD) affects the five-year prognosis of patients with non-small cell lung cancer (NSCLC) who received anti-PD-1 immunotherapy monotherapy. Researchers tracked long-term outcomes to quantify how underlying lung fibrosis or inflammation modifies survival and treatment-related pulmonary complications in this challenging patient group. Pre-existing ILD is a clinically significant concern because anti-PD-1 checkpoint inhibitors can trigger immune-related pneumonitis, a potentially life-threatening side effect that may be more severe and frequent when lung tissue is already compromised. The five-year follow-up window provides unusually long-term evidence compared to most immunotherapy studies, offering insight into whether early risks persist, resolve, or compound over time. These findings are intended to help oncologists weigh the benefits and risks of immunotherapy for NSCLC patients who also carry a diagnosis of ILD, a population historically excluded or underrepresented in pivotal clinical trials.
BMC cancer
Source →4D Time-lapse imaging of cell dynamics in human alveolar tissue by label-free higher harmonic generation microscopy.
Ma Y, et al
Researchers have developed a new imaging platform that uses label-free higher harmonic generation (HHG) microscopy to capture real-time, four-dimensional dynamics of live human lung tissue without the need for dyes or fluorescent labels. The platform combines 3D time-lapse microscopy with a stage-top incubator that keeps tissue slices viable during prolonged imaging sessions, enabling continuous observation of cellular behavior within intact alveolar structures. The study demonstrated that both naturally present immune cells and externally added monocytes could be tracked as they migrated through healthy lung tissue for up to 59 hours, with total culture periods reaching 90 hours. This work addresses a significant gap in current research, where standard methods such as static histology or fixed-endpoint tissue cultures fail to capture the dynamic processes—including immune cell infiltration and extracellular matrix remodeling—that are critical predictors of how patients respond to cancer or fibrosis therapies. The platform is designed to be relatively straightforward to operate and holds strong promise for accelerating drug development and enabling personalized treatment response prediction in human lung disease.
Journal of translational medicine
Source →Comorbidities as predictors of postoperative pulmonary complications after lung cancer surgery.
Caushi F, et al
A study published in the Journal of Cardiothoracic Surgery examined whether pre-existing health conditions, known as comorbidities, can serve as reliable predictors of postoperative pulmonary complications in patients undergoing surgery for lung cancer. Lung cancer surgery remains one of the most physiologically demanding procedures, and postoperative respiratory complications such as pneumonia, atelectasis, and prolonged air leak significantly increase morbidity and hospital stays. The research sought to identify which specific comorbid conditions, such as chronic obstructive pulmonary disease, heart failure, or diabetes, carry the greatest risk for adverse pulmonary outcomes following resection. By establishing comorbidity-based risk profiles, the findings offer clinicians a practical framework for preoperative patient stratification and targeted perioperative care planning. Improved prediction of postoperative pulmonary complications could ultimately guide surgical decision-making, optimize patient selection, and reduce preventable complications in a population that is already medically vulnerable.
Journal of cardiothoracic surgery
Source →